Access Bio (XKRX:950130) Land And Improvements : ₩4,285 Mil (As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Access Bio Land And Improvements?

Access Bio's land and improvements for the quarter that ended in Jun. 2024 was ₩4,285 Mil.

Access Bio's quarterly land and improvements stayed the same from Dec. 2023 (₩4,285 Mil) to Mar. 2024 (₩4,285 Mil) but then increased from Mar. 2024 (₩4,285 Mil) to Jun. 2024 (₩4,285 Mil).

Access Bio's annual land and improvements increased from Dec. 2021 (₩4,161 Mil) to Dec. 2022 (₩4,285 Mil) but then declined from Dec. 2022 (₩4,285 Mil) to Dec. 2023 (₩4,285 Mil).

Access Bio Land And Improvements Historical Data

The historical data trend for Access Bio's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Access Bio Land And Improvements Chart

Access Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Land And Improvements

Get a 7-Day Free Trial

4,107.22

4,161.26

4,285.32

Access Bio Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Land And Improvements	Get a 7-Day Free Trial															4,285.32	4,285.32	4,285.32	4,285.32	4,285.32

Access Bio Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Access Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Clyde Road, Suite A, Somerset, NJ, USA, 08873

Website

http://www.accessbio.net

Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio Headlines

No Headlines